Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial
Chimeric Therapeutics (ASX:CHM) has reported one leukaemia patient has shown a complete response in its latest drug trial.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WWA | Ann: Removal | 22/12/10 | 1 | 829 | |||
|
|||||||
WWA | Ann: Ceasing to be a Substantial Holding | 16/12/10 | 0 | 819 | |||
|
|||||||
WWA | Ann: Change of Director's Interest Notice | 16/12/10 | 0 | 402 | |||
|
|||||||
WWA | Ann: Change of Director's Interest Notice | 16/12/10 | 0 | 366 | |||
|
|||||||
WWA | Ann: Implementation of the Scheme of Arrangement | 16/12/10 | 0 | 908 | |||
|
|||||||
WWA | Ann: Discretionary Special Dividend | 06/12/10 | 0 | 770 | |||
|
|||||||
WWA | Ann: Suspension from Official Quotation | 06/12/10 | 0 | 367 | |||
|
|||||||
WWA | Ann: Wridgways Lodges Court Order With ASIC | 03/12/10 | 0 | 450 | |||
|
See All Discussions